Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 29;19(8):e0294541.
doi: 10.1371/journal.pone.0294541. eCollection 2024.

National diagnostic reference levels for digital diagnostic and screening mammography in Uganda

Affiliations

National diagnostic reference levels for digital diagnostic and screening mammography in Uganda

Denish Odongo et al. PLoS One. .

Abstract

Introduction: Screening and diagnostic mammography are associated with some risk of radiation-induced breast cancer. This study was conducted to establish the National Diagnostic Reference Levels (NDRLs) for digital diagnostic and screening mammography in Uganda to achieve breast radiation dose optimization.

Methods: A cross-sectional study was conducted among female participants recruited by consecutive sampling from three selected hospitals with digital mammography in Uganda. The study variables extracted from the mammography machines were exposure factors, compressed breast thickness (CBT), and Average Glandular Dose (AGD) of two standard mammogram views. The stratified National DRL was derived by calculating the 75th percentile of the AGD across all the samples at various CBT ranges for both screening and diagnostic mammography in craniocaudal (CC) and mediolateral oblique (MLO) views.

Results: We included 300 participants with mean ages of 50.28±9.32 and 47.45±13.45 years for the screening and diagnostic mammography, respectively. There were statistically significant positive correlations between AGD and exposure factors (mAs, kVp) (all p-values<0.0001). For screening mammography, mAs demonstrated a strong positive correlation (r = 0.8369 in CC, 0.8133 in MLO), whereas kVp showed a positive correlation with relatively lower coefficients (r = 0.3700 in CC, 0.3080 in MLO). For diagnostic mammography, mAs exhibited an even stronger positive correlation (r = 0.8987 in CC, 0.8762 in MLO), and kVp maintained a positive correlation with somewhat lower coefficients (r = 0.4954 in CC, 0.3597 in MLO). In screening mammography, for CBT within the range of (7-39) mm, the NDRLs were (1.5mGy, 1.66mGy) in CC) and MLO views. For CBT in the range of (40-59) mm, the NDRLs were (1.78mGy, 1.87mGy), and for CBT in the range of (60-99) mm, the NDRLs were (2.18mGy, 2.22mGy). For diagnostic mammography, the NDRLs were established as (1.7mGy, 1.91mGy), (2.00mGy, 2.09mGy), and (2.63mGy, 2.81mGy) for CBT ranges of (7-39) mm, (40-59) mm, and (60-99) mm, respectively.

Conclusion: The NDRLs for digital screening and diagnostic mammography in Uganda have been proposed for the first time. The NDRL values in mammography should be specific to CBT ranges and mammographic views for both diagnostic and screening mammography.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interest exist.

References

    1. Arnold M., et al., Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast, 2022. 66: p. 15–23. doi: 10.1016/j.breast.2022.08.010 - DOI - PMC - PubMed
    1. Cao W., et al., Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chinese medical journal, 2021. 134(07): p. 783–791. - PMC - PubMed
    1. Zubor P., et al., Why the gold standard approach by mammography demands extension by multiomics? Application of liquid biopsy miRNA profiles to breast cancer disease management. International Journal of Molecular Sciences, 2019. 20(12): p. 2878. doi: 10.3390/ijms20122878 - DOI - PMC - PubMed
    1. Berry D.A., et al., Effect of screening and adjuvant therapy on mortality from breast cancer. New England Journal of Medicine, 2005. 353(17): p. 1784–1792. doi: 10.1056/NEJMoa050518 - DOI - PubMed
    1. Bray F., et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 2018. 68(6): p. 394–424. doi: 10.3322/caac.21492 - DOI - PubMed